|
ZNF830 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.9971000000012E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.37989952797568E-10 |
| Normal-vs-Stage2 |
3.080200E-01 |
| Normal-vs-Stage3 |
9.565800E-01 |
| Normal-vs-Stage4 |
7.811000E-01 |
| Stage1-vs-Stage2 |
3.761400E-03 |
| Stage1-vs-Stage3 |
4.65250005188267E-09 |
| Stage1-vs-Stage4 |
4.51469994722231E-09 |
| Stage2-vs-Stage3 |
3.111200E-01 |
| Stage2-vs-Stage4 |
2.522000E-01 |
| Stage3-vs-Stage4 |
7.656200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.396900E-03 |
| Normal-vs-AfricanAmerican |
4.11540000000432E-05 |
| Normal-vs-Asian |
6.175600E-02 |
| Caucasian-vs-AfricanAmerican |
1.158190E-03 |
| Caucasian-vs-Asian |
1.747830E-01 |
| AfricanAmerican-vs-Asian |
9.751800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.819900E-03 |
| Normal-vs-Female |
7.98039999971856E-07 |
| Male-vs-Female |
5.179500E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.233390E-01 |
| Normal-vs-Age(41-60Yrs) |
1.568450E-04 |
| Normal-vs-Age(61-80Yrs) |
9.611600E-04 |
| Normal-vs-Age(81-100Yrs) |
9.624800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.444200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.380200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.104800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.523600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.005610E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.479560E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.63935531816151E-12 |
| Normal-vs-Grade 2 |
1.25579990850611E-10 |
| Normal-vs-Grade 3 |
2.524800E-01 |
| Normal-vs-Grade 4 |
8.559900E-02 |
| Grade 1-vs-Grade 2 |
1.436020E-03 |
| Grade 1-vs-Grade 3 |
2.21789997478794E-09 |
| Grade 1-vs-Grade 4 |
6.22846219044959E-12 |
| Grade 2-vs-Grade 3 |
9.32160004740723E-09 |
| Grade 2-vs-Grade 4 |
7.86359866111752E-12 |
| Grade 3-vs-Grade 4 |
1.024010E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.75348624509297E-12 |
| Normal-vs-ccB subtype |
2.368800E-01 |
| ccA subtype-vs-ccB subtype |
2.22044604925031E-16 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.209900E-02 |
| Normal-vs-N1 |
7.122200E-01 |
| N0-vs-N1 |
2.476000E-01 |
|
|
